Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction. Horiuchi Y, Wettersten N, Patel MP, Mueller C, et al. Circulation 2020 Aug 21. doi: 10.1161/CIRCULATIONAHA.120.046682.

Read + Share

Amedeo Smart

Independent Medical Education

Horiuchi Y, Wettersten N, Patel MP, Mueller C, et al. Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction. Circulation 2020 Aug 21. doi: 10.1161/CIRCULATIONAHA.120.046682.
PMID: 32820656